Veru Inc. (VERU): Operating Cash Flow
-$30.04M
Year ended 2025-09-30
-$26.04M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$30.04M | n/m | 2025-12-17, From 2024-10-01 |
| 2024-09-30 | -$21.68M | n/m | 2025-12-17, From 2023-10-01 |
| 2023-09-30 | -$88.01M | n/m | 2024-12-16, From 2022-10-01 |
| 2022-09-30 | -$47.51M | n/m | 2024-04-01, From 2021-10-01 |
| 2021-09-30 | -$15.57M | n/m | 2022-12-05, From 2020-10-01 |
| 2020-09-30 | -$1.93M | n/m | 2021-12-02, From 2019-10-01 |
| 2019-09-30 | -$5.49M | n/m | 2020-12-10, From 2018-10-01 |
| 2018-09-30 | -$11.55M | n/m | 2019-12-12, From 2017-10-01 |
| 2017-09-30 | $982.9K | n/m | 2018-12-13, From 2016-10-01 |
| 2016-09-30 | -$1.71M | n/m | 2018-01-02, From 2015-10-01 |
| 2015-09-30 | -$1.55M | n/m | 2018-01-02, From 2014-10-01 |
| 2014-09-30 | $3.67M | -68.9% | 2016-12-12, From 2013-10-01 |
| 2013-09-30 | $11.79M | +13.9% | 2013-12-03, From 2012-10-01 |
| 2012-09-30 | $10.36M | +48.6% | 2013-12-03, From 2011-10-01 |
| 2011-09-30 | $6.97M | +74.6% | 2013-12-03, From 2010-10-01 |
| 2010-09-30 | $3.99M | -30.5% | 2012-12-04, From 2009-10-01 |
| 2009-09-30 | $5.75M | n/a | 2011-12-02, From 2008-10-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Veru Inc. (VERU) | 2025-09-30 | -$30.04M | n/m |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | $322.0K | n/m |
| Talphera, Inc. (TLPH) | 2025-12-31 | -$11.36M | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$5.33M | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$33.12M | n/m |
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | -$27.75M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $148.3K | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$12.35M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$13.36M | n/m |
Compare VERU, SLGL, TLPH, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗